NANOVIRICIDES, INC. Operating Cash Flow
NANOVIRICIDES, INC. (NNVC) reported Operating Cash Flow of -$5.57 million for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-05-15
- NANOVIRICIDES, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.93M.
- NANOVIRICIDES, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$2.05M.
- NANOVIRICIDES, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.59M.
- NANOVIRICIDES, INC. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$1.70M.
- NANOVIRICIDES, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$8.48M.
- NANOVIRICIDES, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$6.32M.
- NANOVIRICIDES, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$5.67M.
- NANOVIRICIDES, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$5.89M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed | Net Cash Provided by (Used in) Operating Activities 77 month | Net Cash Provided by (Used in) Operating Activities 80 month | Net Cash Provided by (Used in) Operating Activities 83 month | Net Cash Provided by (Used in) Operating Activities 86 month | Net Cash Provided by (Used in) Operating Activities 89 month | Net Cash Provided by (Used in) Operating Activities 92 month | Net Cash Provided by (Used in) Operating Activities 95 month | Net Cash Provided by (Used in) Operating Activities 99 month | Net Cash Provided by (Used in) Operating Activities 101 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | -$3.98M derived: sum of 2 quarters · filed 2026-05-15 | -$5.57M 10-Q · filed 2026-05-15 | -$7.28M derived: sum of 4 quarters · filed 2026-05-15 | |||||||||||
| 2025-12-31 | -$2.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-17 | -$3.64M 10-Q · filed 2026-02-17 | -$5.35M derived: sum of 3 quarters · filed 2026-02-17 | -$7.34M derived: sum of 4 quarters · filed 2026-05-15 | |||||||||||
| 2025-09-30 | -$1.59M 10-Q · filed 2025-11-14 | -$3.30M derived: sum of 2 quarters · filed 2025-11-14 | -$5.29M derived: sum of 3 quarters · filed 2026-05-15 | -$7.48M derived: sum of 4 quarters · filed 2026-05-15 | |||||||||||
| 2025-06-30 | -$1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | -$3.69M derived: sum of 2 quarters · filed 2026-05-15 | -$5.88M derived: sum of 3 quarters · filed 2026-05-15 | -$8.48M 10-K · filed 2025-09-29 | |||||||||||
| 2025-03-31 | -$1.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-15 | -$4.18M derived: sum of 2 quarters · filed 2026-05-15 | -$6.78M 10-Q · filed 2026-05-15 | -$8.26M derived: sum of 4 quarters · filed 2026-05-15 | |||||||||||
| 2024-12-31 | -$2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-17 | -$4.79M 10-Q · filed 2026-02-17 | -$6.27M derived: sum of 3 quarters · filed 2026-02-17 | -$8.21M derived: sum of 4 quarters · filed 2026-02-17 | |||||||||||
| 2024-09-30 | -$2.59M 10-Q · filed 2025-11-14 | -$4.08M derived: sum of 2 quarters · filed 2025-11-14 | -$6.02M derived: sum of 3 quarters · filed 2025-11-14 | -$7.74M derived: sum of 4 quarters · filed 2025-11-14 | |||||||||||
| 2024-06-30 | -$1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | -$3.42M derived: sum of 2 quarters · filed 2025-09-29 | -$5.14M derived: sum of 3 quarters · filed 2025-09-29 | -$6.32M 10-K · filed 2025-09-29 | |||||||||||
| 2024-03-31 | -$1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-15 | -$3.66M derived: sum of 2 quarters · filed 2025-05-15 | -$4.83M 10-Q · filed 2025-05-15 | -$6.33M derived: sum of 4 quarters · filed 2025-05-15 | |||||||||||
| 2023-12-31 | -$1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-14 | -$2.89M 10-Q · filed 2025-02-14 | -$4.39M derived: sum of 3 quarters · filed 2025-02-14 | -$6.13M derived: sum of 4 quarters · filed 2025-02-14 | |||||||||||
| 2023-09-30 | -$1.17M 10-Q · filed 2024-11-14 | -$2.67M derived: sum of 2 quarters · filed 2024-11-14 | -$4.41M derived: sum of 3 quarters · filed 2024-11-14 | -$5.81M derived: sum of 4 quarters · filed 2024-11-14 | |||||||||||
| 2023-06-30 | -$1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-27 | -$3.24M derived: sum of 2 quarters · filed 2024-09-27 | -$4.64M derived: sum of 3 quarters · filed 2024-09-27 | -$5.67M 10-K · filed 2024-09-27 | |||||||||||
| 2023-03-31 | -$1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | -$3.14M derived: sum of 2 quarters · filed 2024-05-15 | -$4.17M 10-Q · filed 2024-05-15 | -$5.57M derived: sum of 4 quarters · filed 2024-05-15 | |||||||||||
| 2022-12-31 | -$1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | -$2.43M 10-Q · filed 2024-02-14 | -$3.83M derived: sum of 3 quarters · filed 2024-02-14 | -$5.49M derived: sum of 4 quarters · filed 2024-02-14 | |||||||||||
| 2022-09-30 | -$1.03M 10-Q · filed 2023-11-14 | -$2.43M derived: sum of 2 quarters · filed 2023-11-14 | -$4.09M derived: sum of 3 quarters · filed 2023-11-14 | -$6.20M derived: sum of 4 quarters · filed 2023-11-14 | |||||||||||
| 2022-06-30 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-13 | -$3.05M derived: sum of 2 quarters · filed 2023-10-13 | -$5.17M derived: sum of 3 quarters · filed 2023-10-13 | -$5.89M 10-K · filed 2023-10-13 | |||||||||||
| 2022-03-31 | -$1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | -$3.77M derived: sum of 2 quarters · filed 2023-05-15 | -$4.49M 10-Q · filed 2023-05-15 | -$6.72M derived: sum of 4 quarters · filed 2023-05-15 | |||||||||||
| 2021-12-31 | -$2.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-14 | -$2.84M 10-Q · filed 2023-02-14 | -$5.07M derived: sum of 3 quarters · filed 2023-02-14 | -$6.50M derived: sum of 4 quarters · filed 2023-02-14 | |||||||||||
| 2021-09-30 | -$724.23K 10-Q · filed 2022-11-14 | -$2.95M derived: sum of 2 quarters · filed 2022-11-14 | -$4.39M derived: sum of 3 quarters · filed 2022-11-14 | -$6.70M derived: sum of 4 quarters · filed 2022-11-14 | |||||||||||
| 2021-06-30 | -$2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-13 | -$3.66M derived: sum of 2 quarters · filed 2022-10-13 | -$5.98M derived: sum of 3 quarters · filed 2022-10-13 | -$8.21M 10-K · filed 2022-10-13 | -$8.21M 10-K · filed 2021-10-12 | ||||||||||
| 2021-03-31 | -$1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | -$3.75M derived: sum of 2 quarters · filed 2022-05-16 | -$5.99M 10-Q · filed 2022-05-16 | -$7.69M derived: sum of 4 quarters · filed 2022-05-16 | |||||||||||
| 2020-12-31 | -$2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | -$4.55M 10-Q · filed 2022-02-14 | -$6.26M derived: sum of 3 quarters · filed 2022-02-14 | -$8.66M derived: sum of 4 quarters · filed 2022-02-14 | |||||||||||
| 2020-09-30 | -$2.24M 10-Q · filed 2021-11-15 | -$3.94M derived: sum of 2 quarters · filed 2021-11-15 | -$6.34M derived: sum of 3 quarters · filed 2021-11-15 | -$7.47M derived: sum of 4 quarters · filed 2021-11-15 | |||||||||||
| 2020-06-30 | -$1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-12 | -$4.11M derived: sum of 2 quarters · filed 2021-10-12 | -$5.23M derived: sum of 3 quarters · filed 2021-10-12 | -$6.67M 10-K · filed 2021-10-12 | |||||||||||
| 2020-03-31 | -$2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14 | -$3.52M derived: sum of 2 quarters · filed 2021-05-14 | -$4.96M 10-Q · filed 2021-05-14 | -$5.11M 10-Q · filed 2020-06-22 | -$6.63M derived: sum of 4 quarters · filed 2021-10-12 | ||||||||||
| 2019-12-31 | -$1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16 | -$2.56M 10-Q · filed 2021-02-16 | -$4.23M derived: sum of 3 quarters · filed 2021-10-12 | -$6.24M derived: sum of 4 quarters · filed 2021-10-12 | |||||||||||
| 2019-09-30 | -$1.43M 10-Q · filed 2020-11-16 | -$3.11M derived: sum of 2 quarters · filed 2021-10-12 | -$5.12M derived: sum of 3 quarters · filed 2021-10-12 | -$7.27M derived: sum of 4 quarters · filed 2021-10-12 | |||||||||||
| 2019-06-30 | -$1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-12 | -$3.68M derived: sum of 2 quarters · filed 2021-10-12 | -$5.84M derived: sum of 3 quarters · filed 2021-10-12 | -$6.80M 10-K · filed 2021-10-12 | |||||||||||
| 2019-03-31 | -$2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-22 | -$4.17M derived: sum of 2 quarters · filed 2020-06-22 | -$5.13M 10-Q · filed 2020-06-22 | -$8.65M derived: sum of 4 quarters · filed 2020-10-13 | |||||||||||
| 2018-12-31 | -$2.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | -$3.12M 10-Q · filed 2020-02-14 | -$6.64M derived: sum of 3 quarters · filed 2020-10-13 | -$7.94M derived: sum of 4 quarters · filed 2020-10-13 | |||||||||||
| 2018-09-30 | -$962.15K 10-Q · filed 2019-11-15 | -$4.48M derived: sum of 2 quarters · filed 2020-10-13 | -$5.78M derived: sum of 3 quarters · filed 2020-10-13 | -$7.18M derived: sum of 4 quarters · filed 2020-10-13 | |||||||||||
| 2018-06-30 | -$3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-13 | -$4.82M derived: sum of 2 quarters · filed 2020-10-13 | -$6.22M derived: sum of 3 quarters · filed 2020-10-13 | -$7.78M 10-K · filed 2020-10-13 | |||||||||||
| 2018-03-31 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-15 | -$2.70M derived: sum of 2 quarters · filed 2019-05-15 | -$4.26M 10-Q · filed 2019-05-15 | -$5.27M derived: sum of 4 quarters · filed 2019-08-23 | |||||||||||
| 2017-12-31 | -$1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-14 | -$2.96M 10-Q · filed 2019-02-14 | -$3.97M derived: sum of 3 quarters · filed 2019-08-23 | -$6.02M derived: sum of 4 quarters · filed 2019-08-23 | |||||||||||
| 2017-09-30 | -$1.56M 10-Q · filed 2018-11-14 | -$2.57M derived: sum of 2 quarters · filed 2019-08-23 | -$4.62M derived: sum of 3 quarters · filed 2019-08-23 | -$7.23M derived: sum of 4 quarters · filed 2019-08-23 | |||||||||||
| 2017-06-30 | -$1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-23 | -$3.06M derived: sum of 2 quarters · filed 2019-08-23 | -$5.67M derived: sum of 3 quarters · filed 2019-08-23 | -$7.90M 10-K · filed 2019-08-23 | |||||||||||
| 2017-03-31 | -$2.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-21 | -$4.66M derived: sum of 2 quarters · filed 2018-05-21 | -$6.89M 10-Q · filed 2018-05-21 | ||||||||||||
| 2016-12-31 | -$2.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-20 | -$4.84M 10-Q · filed 2018-02-20 | |||||||||||||
| 2016-09-30 | -$2.22M 10-Q · filed 2017-11-14 | ||||||||||||||
| 2016-06-30 | -$6.83M 10-K · filed 2018-10-12 | ||||||||||||||
| 2013-09-30 | -$1.32M 10-Q/A · filed 2013-11-18 | -$27.28M 10-Q/A · filed 2013-11-18 | |||||||||||||
| 2013-06-30 | -$5.80M 10-K/A · filed 2013-10-08 | -$25.96M 10-K/A · filed 2013-10-08 | |||||||||||||
| 2013-03-31 | -$1.71M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-05-20 | -$3.08M derived: sum of 2 quarters · filed 2013-05-20 | -$4.43M 10-Q/A · filed 2013-05-20 | -$5.32M derived: sum of 4 quarters · filed 2013-11-18 | -$24.59M 10-Q/A · filed 2013-05-20 | ||||||||||
| 2012-12-31 | -$1.37M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-02-22 | -$2.72M 10-Q/A · filed 2013-02-22 | -$3.61M derived: sum of 3 quarters · filed 2013-11-18 | -$5.03M derived: sum of 4 quarters · filed 2013-11-18 | -$22.88M 10-Q/A · filed 2013-02-22 | ||||||||||
| 2012-09-30 | -$1.35M 10-Q/A · filed 2013-11-18 | -$2.24M derived: sum of 2 quarters · filed 2013-11-18 | -$3.66M derived: sum of 3 quarters · filed 2013-11-18 | -$4.89M derived: sum of 4 quarters · filed 2013-11-18 | -$21.51M 10-Q · filed 2012-11-19 | ||||||||||
| 2012-06-30 | -$896.55K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2013-10-08 | -$2.32M derived: sum of 2 quarters · filed 2013-10-08 | -$3.54M derived: sum of 3 quarters · filed 2013-10-08 | -$4.22M 10-K/A · filed 2013-10-08 | -$20.16M 10-K/A · filed 2012-10-26 | ||||||||||
| 2012-03-31 | -$1.42M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-05-20 | -$2.65M derived: sum of 2 quarters · filed 2013-05-20 | -$3.32M 10-Q/A · filed 2013-05-20 | -$3.32M 10-Q · filed 2012-05-21 | -$4.16M derived: sum of 4 quarters · filed 2013-05-20 | -$19.27M 10-Q · filed 2012-05-21 | |||||||||
| 2011-12-31 | -$1.23M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2013-02-22 | -$1.90M 10-Q/A · filed 2013-02-22 | -$2.74M derived: sum of 3 quarters · filed 2013-02-22 | -$3.96M derived: sum of 4 quarters · filed 2013-02-22 | -$17.85M 10-Q · filed 2012-02-14 | ||||||||||
| 2011-09-30 | -$676.27K 10-Q · filed 2012-11-19 | -$1.52M derived: sum of 2 quarters · filed 2012-11-19 | -$2.74M derived: sum of 3 quarters · filed 2012-11-19 | -$3.74M derived: sum of 4 quarters · filed 2012-11-19 | -$16.62M 10-Q/A · filed 2011-12-12 | ||||||||||
| 2011-06-30 | -$841.09K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-10-26 | -$2.06M derived: sum of 2 quarters · filed 2012-10-26 | -$3.06M derived: sum of 3 quarters · filed 2012-10-26 | -$4.51M 10-K/A · filed 2012-10-26 | |||||||||||
| 2011-03-31 | -$1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-21 | -$2.22M derived: sum of 2 quarters · filed 2012-05-21 | -$3.67M 10-Q · filed 2012-05-21 | ||||||||||||
| 2010-12-31 | -$999.47K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-02-14 | -$2.45M 10-Q · filed 2012-02-14 | |||||||||||||
| 2010-09-30 | -$1.45M 10-Q/A · filed 2011-12-12 | ||||||||||||||
| 2010-06-30 | -$2.05M 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |